NCT04422470 - Registry of Patients With Hematologic Disease and COVID-19 in Russia | Biotech Hunter

Enrollment

666

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

August 22, 2021

Study Completion Date

January 18, 2022

Conditions

Coronavirus Infection and Hematologic Diseases

Interventions

OTHER

Non-interventional study

Trial Locations (15)

RM Gorbacheva Research Institute of Pediatric Oncology, Hematology and Transplantation, Pavlov University, Saint Petersburg

Republican Clinical Hospital of Tatarstan, Kazan'

City Hospital n.a. V.V. Veresaev, Moscow

Clinical Hospital n.a. S.P. Botkin, Moscow

N.V. Sklifosovsky Emergency Institute, Moscow

National Research Center for Hematology, Moscow

Regional Clinical Hospital N.A. Semashko, Nizhny Novgorod

Regional Hospital, Novosibirsk

Regional Clinical Hospital, Omsk

Republican Clinical Hospital No4, Saransk

Republic Clinical Hospital n.a. N.A. Semashko, Ulan-Ude

Regional Clinical Hospital, Vladimir

Regional Clinical Hospital No2, Vladivostok

Regional Clinical Hospital, Yaroslavl

Regional Clinical Hospital No1, Yekaterinburg

All Listed Sponsors

collaborator

Foundation for Cancer Research Support (RakFond)

UNKNOWN

collaborator

Enrollme.ru, LLC

NETWORK

lead

National Research Center for Hematology, Russia

NETWORK